Skip to main content
    G

    GSK plc (GSK)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $50.41
    -0.04 (-0.07%)

    Market Cap: $101.13B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    GSK plc (GSK) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to GSK are Bristol-Myers Squibb Company (BMY), Sanofi ADR (SNY) and Gilead Sciences (GILD). GSK trades at 10.5x earnings, against a median of 19.9x for the 9 of these companies with a P/E. By market cap, GSK ranks 11th of the 13 companies on this page; AbbVie (ABBV) is the largest at $521.50B.

    Peer Comparison

    GSK's revenue growth of 4.0% is below the peer median of 6.8%. Its dividend yield is above the peer median of 2.35%.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    GSK (GSK)$101.13B10.5x2.3x13.0%N/A4.0%3.58%
    Bristol-Myers Squibb Company (BMY)$129.66B10.1x2.6x18.5%13.9%6.9%4.00%
    Sanofi ADR (SNY)$116.15BN/A2.0x8.2%7.6%15.7%5.01%
    Gilead Sciences Inc (GILD)$208.48BN/A6.7x-12.5%-3.9%6.8%1.96%
    Pfizer Inc (PFE)$164.67B9.5x2.6x6.3%2.7%-0.4%5.96%
    Novo Nordisk A/S (NVO)$183.52BN/A3.6x33.9%34.1%5.6%4.32%
    AstraZeneca PLC (AZN)$286.07B22.5x4.6x17.7%14.9%6.7%1.16%
    Amgen Inc (AMGN)$251.89B19.9x6.4x24.1%17.0%8.5%2.18%
    Biogen Inc (BIIB)$37.46B21.4x3.6x3.4%1.3%10.6%0.00%
    Novartis AG ADR (NVS)$303.12B18.7x5.4x17.5%13.5%4.7%2.98%
    Merck & Company Inc (MRK)$364.26B46.3x5.3x3.6%3.1%4.7%2.35%
    Grifols SA ADR (GRFS)$5.91B9.9x0.7x6.4%7.6%9.4%1.08%
    AbbVie Inc (ABBV)$521.50B23.0x7.9x15.7%16.4%10.3%2.35%
    Peer median$196.00B19.9x4.1x11.9%10.5%6.8%2.35%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to GSK, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - General.

    CompanyAboutPeers
    Bristol-Myers Squibb Company (BMY)
    Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City.
    BMY competitors
    Sanofi ADR (SNY)
    Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe...
    SNY competitors
    Gilead Sciences Inc (GILD)
    Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California...
    GILD competitors
    Pfizer Inc (PFE)
    Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City.
    PFE competitors
    Novo Nordisk A/S (NVO)
    Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally.
    NVO competitors
    AstraZeneca PLC (AZN)
    AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory...
    AZN competitors
    Amgen Inc (AMGN)
    Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
    AMGN competitors
    Biogen Inc (BIIB)
    Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development...
    BIIB competitors
    Novartis AG ADR (NVS)
    Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
    NVS competitors
    Merck & Company Inc (MRK)
    Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey.
    MRK competitors
    Grifols SA ADR (GRFS)
    Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives.
    GRFS competitors
    AbbVie Inc (ABBV)
    AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
    ABBV competitors

    Frequently Asked Questions About GSK

    Who are GSK's main competitors?

    The companies most similar to GSK include Bristol-Myers Squibb Company (BMY), Sanofi ADR (SNY), Gilead Sciences (GILD), Pfizer (PFE) and Novo Nordisk A/S (NVO), listed from the closest match.

    Who is GSK's biggest competitor?

    AbbVie (ABBV) is the largest of the similar companies at $521.50B; Bristol-Myers Squibb Company (BMY) is the closest match by business profile, size, sector and industry.

    How does GSK stock compare with its competitors?

    GSK's P/E is 10.5x against a peer median of 19.9x; its P/S is 2.3x against a peer median of 4.1x; its net margin is 13.0% against a peer median of 11.9%.

    Which of GSK's competitors pays a higher dividend?

    GSK has a forward dividend yield of 3.58%. Pfizer (PFE), Sanofi ADR (SNY), Novo Nordisk A/S (NVO) and Bristol-Myers Squibb Company (BMY) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.

    Is GSK bigger than its competitors?

    No. GSK is 11th by market cap among the 13 companies on this page; the largest is AbbVie (ABBV) at $521.50B.